SALVAGE Trial (Safety And cLinical Value of AutoloGous rEinfusion)
NCT:NCT07712666 · NOT_YET_RECRUITING
廣告
NCT IDNCT07712666
狀態NOT_YET_RECRUITING
開始日期2026-11-01
完成時間2029-08-01
SponsorMayo Clinic (OTHER)
First posted
Last updated
簡要摘要
The investigator hypothesizes intraoperative salvaged red blood cells are a poor substitute for allogenic packed red blood cell transfusions. In addition to providing inadequate resuscitation, salvaged red blood cells can increase the rate of complications, including postoperative electrolyte abnormalities, thrombocytopenia, anemia, and coagulopathy.
官方來源
在 ClinicalTrials.gov 上查看 →資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。